1. Introduction {#sec1-molecules-23-01720}
===============

Reactive oxygen species (ROS) refers to oxygen-containing reactive species and includes superoxide anions (O~2~^−^), hydrogen peroxide (H~2~O~2~), and hydroxyl radicals (•OH) \[[@B1-molecules-23-01720]\]. Under normal conditions, ROS are in a constant dynamic state of production and elimination in vivo. They play an important role in physiological metabolic processes such as enhancing leukocyte phagocytosis and prostaglandin synthesis, and participating in enzymatic pathways that contribute to immunity \[[@B2-molecules-23-01720]\]. A net excess of ROS can follow an imbalance in ROS production and elimination. This can lead to a series of peroxidation reactions, cross-linking or breakages with subsequent cellular structural damage and dysfunction. If this occurs chronically, a number of pathophysiological processes may ensue including arteriosclerosis, cardiovascular diseases, neurodegenerative diseases, cancers, and other disorders associated with aging \[[@B3-molecules-23-01720],[@B4-molecules-23-01720],[@B5-molecules-23-01720],[@B6-molecules-23-01720]\]. Therefore, elimination of excess ROS in the body is important for maintaining physiological health. Recently, there has been an increase in interest in antioxidants as substances that protect against oxidative damage. A particular focus has been secondary plant polyphenol or phenolic metabolites such as catechins, epigallocatechin gallate, and catechin-aldehyde polycondensates \[[@B7-molecules-23-01720],[@B8-molecules-23-01720],[@B9-molecules-23-01720]\]. These phenolic compounds also possess other bioactivities including antimicrobial and anti-inflammatory effects \[[@B10-molecules-23-01720],[@B11-molecules-23-01720]\]. Therefore, screening for antioxidants could be an effective strategy for sourcing new drugs or functional foods.

*Loropetalum*, as a member of the *Hamamelidaceae* family, contains three species (*Loropetalum lanceum* Hand-Mzt, *Loropetalum subcapitatum* Chun ex Chang, and *Loropetalum chinense* (*R. Brown*) Oliv.) as well as one variety (*Loropetalum chinense* var. rubrum) in China. Among them, *Loropetalum chinense* (*R. Brown*) Oliv. (LCO), an evergreen shrub or small arbor, was first recorded officially in the 1970 edition of the Chinese pharmacopoeia. LCO has antipyretic, hemostatic, and detoxificant effects, and is a traditional medicine widely used in the treatment of bleeding disorders, burns, skin infections, dysentery, and diarrhea \[[@B12-molecules-23-01720]\]. Modern pharmacological research has shown that LCO has bacteriostatic, anti-inflammatory, healing, and antioxidant effects \[[@B13-molecules-23-01720]\].

The multiple biological activities of LCO are attributed to its diverse constituents. Phytochemical studies reported the presence of tannins, flavonoids, lignans, terpenoids, and steroids in LCO \[[@B14-molecules-23-01720],[@B15-molecules-23-01720],[@B16-molecules-23-01720],[@B17-molecules-23-01720]\]. Alkanes, aldehydes, and terpenoids have been identified as the dominant constituents of LCO essential oil \[[@B13-molecules-23-01720]\]. However, there is little information on the biological constituents that have antioxidant effects. In earlier work, we used DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging activity to evaluate the antioxidant effects of four fractions (water, and 10%, 70%, and 95% ethanol eluates) separated with HPD-400 macroporous resin. Our results showed that the four fractions exhibited various antioxidant effects. The 50% inhibitory concentrations (IC~50~) were 22.53 μg/mL for the water eluate, 11.47 μg/mL for 10% ethanol eluate, 9.73 μg/mL for 70% ethanol eluate and 39.20 μg/mL for 95% ethanol eluate \[[@B18-molecules-23-01720]\]. However, this work only assessed the antioxidant effects of various LCO fractions. Details of the specific constituents responsible for the antioxidant activities remain unclear.

Therefore, in the present study, we used UHPLC-Q-TOF-MS/MS to systemically analyze the chemical constituents of the ethanol extract of LCO to identify the components responsible for its antioxidant effects.

2. Materials and Methods {#sec2-molecules-23-01720}
========================

2.1. Chemicals and Reagents {#sec2dot1-molecules-23-01720}
---------------------------

DPPH and vitamin C (V~C~) were purchased from Sigma Chemicals (Shanghai, China). Chemical standards of gallic acid, protocatechuic acid, quercetin, kaempferol, and chlorogenic acid were obtained from Chengdu Munster Biotechnology Co., Ltd. (Chengdu, China). LC-MS grade methanol and HPLC grade methanol for use as solvents, and acetic acid, formic acid, and acetonitrile were purchased from Fisher Scientific (Shanghai, China). HPD-400 macroporous resin was purchased from Cangzhou Bon Adsorber Technology Co., Ltd (Jiangsu, China). Various types of silica gel were obtained from Qingdao Haiyang Chemical Co., Ltd (Shandong, China). Double distilled water was used in the LC mobile phase. All other chemicals used were analytical grade.

2.2. Plant Material and Extraction {#sec2dot2-molecules-23-01720}
----------------------------------

LCO was collected in May around the city of Jindezhen (29°25′ N, 117°16′ E) (Jiangxi province, China). Plants were authenticated by Prof. Shi-lin Yang, Jiangxi University of Traditional Chinese Medicine. A voucher specimen (No. 20100521) was stored in the National Pharmaceutical Engineering Center for Solid Preparation in Chinese Materia Medica, Jiangxi University of Traditional Chinese Medicine.

Extraction parameters were as described in earlier work by our group \[[@B19-molecules-23-01720]\]. Dried branches and leaves of LCO (17 kg) were milled and reflux-extracted twice with an 8-fold weight of 60% ethanol solution for 2 h. Extracts were then combined and filtered with vacuum suction filtration. The combined filtrates were concentrated to dryness under vacuum with a rotary evaporator to yield a yellowish-brown residue (2.754 kg) that was stored at 4 °C until needed. The residue was re-dissolved with methanol to give a final concentration of 10 mg/mL and then filtered through a 0.22 μm filter membrane before UHPLC analysis.

2.3. DPPH Assay {#sec2dot3-molecules-23-01720}
---------------

DPPH, control, blank and sample solutions were prepared as follows. DPPH solution: 3 mg DPPH was dissolved in absolute ethanol and mixed with 0.03 g/L reaction solution protected from light. Control: 1 mL solvent and 3 mL DPPH solution were combined in a test tube, shaken to mix and left to react for 30 min in the dark at room temperature (25 °C). Absorbance (A~0~) was then measured at a wavelength of 517 nm with a UV visible spectrophotometer (UV-2550, Shimadzu, Kyoto, Japan). Blank: Various concentrations of sample solution (1 mL) were added to 3 mL absolute ethanol in a test tube, shaken to mix, and then stored in the dark at 25 °C. After 30 min, absorbance (A~j~) was measured at 517 nm wavelength. Sample: Various concentrations of sample solution (1 mL) were mixed with 3 mL DPPH solution in a test tube, stored in the dark at 25 °C for 30 min before measuring the absorbance (A~i~) at a wavelength of 517 nm \[[@B20-molecules-23-01720],[@B21-molecules-23-01720],[@B22-molecules-23-01720]\]. The scavenging rate was calculated as follows: scavenging activity (%) = \[1 − (A~i~ − A~j~)/A~0~\] × 100.

2.4. UHPLC--Q-TOF-MS/MS Analysis of the Crude Extract {#sec2dot4-molecules-23-01720}
-----------------------------------------------------

Chromatographic analysis was carried out on a Prominence™ UHPLC system (Shimadzu, Japan) coupled with a triple TOF™ 5600+ MS/MS system (AB Sciex, Framingham, MA, USA). Separations were accomplished on a Welch C~18~ column (2.1 mm × 100 mm, 1.8 μm, Shanghai, China) and 2 μL injected into UHPLC. The column oven was maintained at 40 °C. A linear gradient elution of eluents A (water containing 0.1% formic acid) and B (acetonitrile) was used for separation. The elution program was: 0.1--2 min, 1--5% B; 2.01--20 min, 8--37% B; 20--22 min, 37--50% B; 22--32 min, 50--90% B; 32.01--35 min, 95--95% B, 35.01--40 min, 1% B. The flow rate was 0.25 mL/min.

The mass spectrometer was operated both in negative and positive ion modes. The following parameter settings were used: ion spray voltage 4500 V; turbo spray temperature 600 °C; curtain gas 25 psi, nebulizer gas (GS 1) 50 psi, heater gas (GS 2) 50 psi, declustering potential 100 V. TOF MS and TOF MS/MS were scanned with the mass range of *m*/*z* 50--1250 and 50--1250, respectively. In the IDA-MS/MS experiment, collision energy was set at 35 eV and collision energy spread was (±) 10 eV. Accurate mass and composition for the precursor and fragment ions were analyzed using Peakview software (Version 1.2, AB Sciex) integrated with the instrument.

2.5. Isolation of the Crude Extract {#sec2dot5-molecules-23-01720}
-----------------------------------

The crude extract solution was adsorbed by the HPD-400 macroporous resin and eluted with water, and 10%, 70%, and 95% ethanol-water. The 10% and 70% fractions were concentrated under vacuum to recover the organic solvent to dryness. They were then isolated using various chromatographic techniques including silica gel, Sephadex LH-20, ODS, and MCI columns, and re-crystallization methods.

The compounds were identified using UV, MS, ^1^H-NMR, and ^13^C-NMR experiments along with comparison of their spectroscopic properties from the literature. Their antioxidant activities were measured by DPPH assay.

3. Results {#sec3-molecules-23-01720}
==========

3.1. UHPLC--Q-TOF-MS/MS Analysis of the Crude Extract {#sec3dot1-molecules-23-01720}
-----------------------------------------------------

To obtain the abundant constituents from LCO, UHPLC conditions (type of column, mobile phase system, column temperature, and flow rate) were first optimized followed by the MS conditions (capillary voltage, declustering potential, and collision energy). UHPLC-Q-TOF-MS/MS in positive (A) and negative (B) ion modes was employed to characterize the corresponding signals. The base peak chromatogram under optimized chromatographic and MS conditions are presented in [Figure 1](#molecules-23-01720-f001){ref-type="fig"}. Retention times, observed molecular weight, and fragment ions for each metabolite, and their identities are presented in [Table 1](#molecules-23-01720-t001){ref-type="table"}. A total of 100 compounds were identified or tentatively characterized including 42 gallic acid tannins, 49 flavones, and 9 phenolic compounds. The structures of these compounds were tentatively assigned by matching the MS/MS data with a reference or public database such as PubChem (<https://pubchem.ncbi.nlm.nih.gov/>) or MassBank (<http://www.massbank.jp/>).

### 3.1.1. Fragmentation of Gallic Acid Tannins {#sec3dot1dot1-molecules-23-01720}

The 42 tannin compounds have gallic acid and glucose as their basic structural units, which contain or lose C~7~H~6~O~5~ (*m*/*z*: 170), -C~7~H~5~O~5~ (*m*/*z*: 169), -C~7~H~5~O~4~ (*m*/*z*: 153), -C~6~H~5~O~3~ (*m*/*z*: 125) and -C~6~H~11~O~5~ (*m*/*z*: 163) ion fragments in the MS/MS spectrum \[[@B23-molecules-23-01720],[@B24-molecules-23-01720],[@B25-molecules-23-01720],[@B26-molecules-23-01720]\]. For example, in the positive ion of the MS/MS spectrum, the \[M + H\]^+^ ions of peak 5 were found at *m*/*z*: 171.0274, while *m*/*z*: 153.0180 (M + H-H~2~O), 135.0074 (M + H-2H~2~O), 125.0234 (M + H-HCHO~2~) and 107.0128 (M + H-HCHO~2~-H~2~O) fragment ions were consistent with gallic acid (C~7~H~6~O~5~). Therefore, peak 5 was determined to be gallic acid ([Figure 2](#molecules-23-01720-f002){ref-type="fig"}A1). Peak 54 had \[M + H\]^+^ ions at *m*/*z*: 303.0140, and *m*/*z*: 285.0035 (-C~14~H~5~O~7~), 275.0189 (-C~13~H~7~O~7~), 257.0082 (-C~13~H~7~O~6~) and 229.0130 (-C~12~H~5~O~5~) fragment ions were observed in the MS/MS spectrum, which were formed by loss of H~2~O, CO~2,~and CO. Following comparison with the reference substance, peak 54 was determined to be ellagic acid. Peak 4 had \[M + H\]^+^ ions at *m*/*z* 345.0818 in the MS/MS spectrum ([Figure 2](#molecules-23-01720-f002){ref-type="fig"}A2). Three fragment ion at *m*/*z*: 171.0289, 153.0185, and 125.0232 showed that peak 4 contained gallic acid units. Based on these MS/MS data, peak 4 was identified as theogallin (C~14~H~16~O~10~). Under the negative ion mode, peak 11 had \[M − H\]^−^ ions at *m*/*z* 331.0667, and fragment ions at *m*/*z* 169.0148, 151.0031, and 125.0257 indicating the presence of gallic acid units. \[M − H\] ions produce *m*/*z* 169.0148 by losing 162 Da (-C~6~H~10~O~5~), which indicated the presence of hexose units and thus peak 11 peak was determined to be monogalloylglucose.

### 3.1.2. Fragmentation of Flavonoids Compounds {#sec3dot1dot2-molecules-23-01720}

The Retro-Diels-Alder (RDA) cleavage reaction involves loss and rearrangement of flavonoid aglycone C rings in different ways. The main fragment was derived from cleavage of C-C and C-O bonds on the C ring, and neutral fragments such as CO, CO~2~, H~2~O, and C~2~H~2~O. Hexose (*m*/*z*: 162) and pentose (*m*/*z*: 132) fragments often appear in the MS/MS cracking spectrum of flavonoid glycosides \[[@B27-molecules-23-01720],[@B28-molecules-23-01720],[@B29-molecules-23-01720]\]. In this study, flavonoid glycosides produced gallic acid (*m*/*z*: 169) fragments. For example, peak 71 was identified as quercetin (C~15~H~10~O~7~) through comparison with the reference substance. \[M + H\]^+^ ions at *m*/*z*: 303.0305, and RDA cleavage of C~1~-C~2~ and C~3~-C~4~ bonds in the C ring generated the fragment *m*/*z*: 153.0181. After breakage of the C~2~-O and C~10~-O bonds of the C ring, the B ring produced *m*/*z*: 137.0229 by losing two CO. \[M + H\]^+^ ion lost one H~2~O (18 Da) to form *m*/*z*: 285.0037, and one CO (28 Da) to form *m*/*z*: 275.0176 (-C~14~H~10~O~6~). Subsequently, *m*/*z*: 275.0176 (-C~14~H~10~O~6~) was produced *m*/*z*: 257.0436 (C~14~H~8~O~5~) and *m*/*z*: 229.0493 (-C~13~H~8~O~4~) by losing -H~2~O and -CO. As peaks 57, 59, 62, and 85 had the same fragments, they were presumed to be quercetin isomers.

The \[M − H\]^−^ ion of peak 66 at *m*/*z*: 599.1064 was in accordance with the molecular formula C~28~H~24~O~15~ in the negative ion mode. *m*/*z*: 599.1064 lost 152 Da to produce ion at *m*/*z*: 447.0969. The loss of 152 Da from *m*/*z*: 599.1064 and the fragment *m*/*z*: 169.0147 showed the presence of gallic acid units. Fragment *m*/*z*: 447.0969 lost 162 Da to form *m*/*z*: 285.0414, and fragment *m*/*z*: 313.0582 in MS/MS spectrum showed the presence of hexose units. Fragments *m*/*z*: 285.0414, 151.0036, and 125.0245 were consistent with quercetin cleavage. Therefore, peak 66 was identified as astragalin-*O*-gallate ([Figure 2](#molecules-23-01720-f002){ref-type="fig"}B1). As peak 73 had the same fragments, it was presumed to be an isomer of peak 66.

The \[M − H\]^−^ ion at *m*/*z*: 593.1341 of peak 89 was found in the negative ion MS/MS spectrum. Fragments *m*/*z*: 285.0399 and 151.0038 were consistent with kaempferol cleavage. Combined with *m*/*z*: 307.0835, 163.0398, and 145.0296, we speculated that this was tribuloside (C~30~H~26~O~13~) ([Figure 2](#molecules-23-01720-f002){ref-type="fig"}B2), and that peaks 84 and 93 were its isomers.

### 3.1.3. Fragmentation of Quinine Acid Compounds {#sec3dot1dot3-molecules-23-01720}

Nine caffeoylquinic acid compounds, which lost CO (*m*/*z* 28), CO~2~(*m*/*z* 44), and H~2~O (*m*/*z* 18) during MS/MS cleavage, were observed temporarily in this study \[[@B30-molecules-23-01720],[@B31-molecules-23-01720],[@B32-molecules-23-01720]\]. For example, \[M + H\]^+^ ion at *m*/*z*: 193.0706 of peak 3 was matched with the molecular formula, C~7~H~12~O~6~. Compared with \[M + H\]^+^ ions, *m*/*z*:175.0608 ions were less than 18 Da and *m*/*z*: 147.0656 ions were less than 46 Da, which meant that peak 3 contained hydroxyl and carboxyl groups. After comparison with standard products, peak 3 was identified as quinic acid.

The negative MS/MS spectra of peaks 22, 28, 37, and 68 showed the presence of quinic and caffeic acids in the structure. For example, in the MS/MS spectra of peak 22, the \[M − H\]^−^ ion at *m*/*z*: 353.0878 lost 162 Da and acquired *m*/*z* 191.0565, and lost 180 Da and acquired *m*/*z* 173.0445, which confirmed the presence of caffeic acid. In addition, \[M − H\]^−^ ion lost 192 Da and acquired *m*/*z* 161.0242, and lost 174 Da and acquired *m*/*z* 179.0344, which indicated the presence of quinic acid. Therefore, peaks 22, 28, and 37 were identified as caffeoylquinic acid isomers (C~16~H~18~O~9~) and peak 68 was dicaffeoylquinic acid (C~25~H~24~O~12~).

3.2. Structural Identification of Purified Samples {#sec3dot2-molecules-23-01720}
--------------------------------------------------

The 10% ethanol elution (101.2 g) was dissolved in water and then adsorbed by MCI-gel pore resin to obtain five fractions (Fr1--Fr5) by gradient elution of methanol/water (1:0--0:1). Fr1 underwent repeated ODS column chromatography and preparative HPLC to give compound **1**. Compound **2** was obtained by repeated crystallization of Fr3. Separation of Fr4 by ODS column chromatography gave compound **3**.

The 70% ethanol elution (516.2 g) was dissolved in methanol, subjected to column chromatography on silica gel (300--400 mesh) under reduced pressure, and eluted with ethyl acetate:methanol (1:0--1:1) to obtain 10 fractions (Fr1--Fr10). MCI columns, silica gel, ODS, Sephadex LH-20 and re-crystallization chromatographic methods were then use to separate compounds **3**--**8** by Fr1, compounds **9**--**12** by Fr2, compounds **13**--**16** by Fr3, and compounds **17** and **18** by Fr4.

A total of 18 purified compounds were identified using UV, MS, ^1^H-NMR, and ^13^C-NMR methods: 1,2,3,4,6-penta-*O*-galloyl-β-[d]{.smallcaps}-glucose (**1**), 3,4,5-trimethoxyphenyl-(6′-*O*-galloyl)-*O*-β-[d]{.smallcaps}-glucopyranoside (**2**), 6′-*O*-galloylsalidroside (**3**), gallic acid (**4**), protocatechuic acid (**5**), ethyl gallate (**6**), tiliroside (**7**), 3-*O*-coumaroylquinicacid (**8**), kaempferol-3-*O*-β-[d]{.smallcaps}-galactopyranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside (**9**), kaempferol-3-*O*-β-[d]{.smallcaps}-galactopyranoside (**10**), quercetin-3-*O*-β-[d]{.smallcaps}-glucopyranoside (**11**), 5-*O*-caffeoylquinic acid (**12**), 3-*O*-coumaroylquinic acid methyl ester (**13**), 3-*O*-caffeoylquinic acid (**14**), 5-*O*-coumaroylquinic acid (**15**), 3,5-*O*-diocaffeoylquinic acid (**16**), 4,5-*O*-diocaffeoylquinic acid (**17**), 3,4-*O*-diocaffeoylquinic acid (**18**) ([Supplementary Material Figure S1](#app1-molecules-23-01720){ref-type="app"}). Preliminary information on compounds **7**--**10**, **13,** and **15**--**18** has been reported elsewhere \[[@B33-molecules-23-01720]\].

**Compound 1**: ESI-MS *m*/*z*: 939.1109 \[M − H\]^−^; ^1^H-NMR (600 MHz, DMSO) δ: 6.98 (2H, s), 6.92 (2H, s), 6.86 (2H, s), 6.82 (2H, s), 6.77 (2H, s), 6.38 (1H, d, *J* = 8.3 Hz, H-1), 5.95 (1H, t, *J* = 9.6 Hz, H-2), 5.43 (2H, m, H-3,4), 4.99 (1H, d, *J* = 9.8 Hz, H-5), 4.70 (2H, m, H~2~-6).^13^C-NMR (DMSO, 151 MHz) *δ*: 145.97 (C-1′ × 5), 139.58 (C-2′ × 5), 118.54 (C-3′,5′ × 5), 109.35 (C-2′,6′ × 5), 165.05 (C-7′ × 5), 92.16 (C-1), 72.39 (C-2), 72.59 (C-3), 68.23 (C-4), 71.03 (C-5) and 61.92 (C-6). By comparing experimental data with the literature \[[@B34-molecules-23-01720]\], we determined compound **1** to be 1,2,3,4,6-penta-*O*-galloyl-β-[d]{.smallcaps}-glucose (C~41~H~32~O~26~).

**Compound 2**: ESI-MS *m*/*z*: 497.1300 \[M − H\]^−^. ^1^H-NMR (600 MHz, DMSO) δ: 6.30 (2H, s, H-2, 6), 3.64 (6H, s, OMe-3,5), 3.56 (3H, s, OMe-4), 4.92 (1H, d, *J*= 7.7 Hz, H-1′), 3.74 (1H, m, H-2′), 3.30 (3H, m, H-3′,4′,5′), 4.48 (1H, dd, *J* = 11.9 Hz, 1.7 Hz, H-6′a), 4.27 (1H, dd, *J* = 12.0, 5.7 Hz, H-6′b), 6.949 (2H, s, H-2″,6″), 9.25 (2H, br.s, OH-3″,5″), 8.95 (1H, br.s, OH-4″); ^13^C-NMR (151 MHz, DMSO) δ: 154.20 (C-1), 94.71 (C-2,6), 153.61 (C-3,5), 133.08 (C-4), 60.57 (3,5-OMe), 56.13 (4-OMe), 101.14 (C-1′), 73.66 (C-2′), 76.68 (C-3′), 70.17 (C-4′), 74.33 (C-5′), 64.04 (C-6′), 119.87 (C-1″), 109.08 (C-2″, 6″), 146.03 (C-3″, 5″), 138.95 (C-4″) and 166.27 (C-7″). Marrying the experimental data with the literature \[[@B35-molecules-23-01720]\], compound **2** was identified as 3,4,5-trimethoxyphenyl-(6′-*O*-galloyl)-*O*-β-[d]{.smallcaps}-glucopyranoside (C~22~H~26~O~13~).

**Compound 3**: ESI-MS *m*/*z*: 451.1244 \[M − H\]^−^.^1^H-NMR (600 MHz, MeOD) δ: 6.66 (2H, d, *J* = 8.5 Hz, H-2,6), 6.98 (2H, d, *J* = 8.5 Hz, H-3,5), 3.71 (1H, m, Ha-7), 3.93 (1H, m, Hb-7), 2.80 (2H, m, H~2~-8), 4.33 (1H, d, *J* = 7.8 Hz, H-1′), 3.23 (1H, t, *J* = 8.4 Hz, H-2′), 3.41 (2H, m, H-3′,4′), 3.57 (1H, m, H-5′), 4.53 (1H, dd, *J* = 11.8, 2.1 Hz, Ha-6′), 4.44 (1H, dd, *J* = 11.8, 5.8 Hz, Hb-6′), 7.11 (2H, s, H-2″, 6″); ^13^C-NMR (151 MHz, MeOD) δ: 167.01 (COOH), 129.27 (C-1), 129.51 (C-2,6), 114.77 (C-3,5), 155.27 (C-4), 70.39 (C-7), 35.05 (C-8), 103.12 (C-1′), 73.70 (C-2′), 76.58 (C-3′), 70.88 (C-4′), 74.08 (C-5′), 63.40 (C-6′), 120.09 (C-1″), 108.84 (C-2″,6″), 145.15 (C-3″,5″) and 138.49 (C-4″). By comparing experimental data with the literature \[[@B36-molecules-23-01720]\], compound **3** was identified as 6′-*O*-galloylsalidroside (C~21~H~24~O~11~).

**Compound 4**: ESI-MS *m*/*z*: 169.0145 \[M − H\]^−^.^1^H-NMR (600 MHz, DMSO) *δ*: 12.20 (1H, br.s, COOH), 9.15 (2H, br.s, OH-3,5), 8.80 (1H, br.s, OH-4), 6.937 ( 2H, s, H-2,6); ^13^C-NMR (DMSO,151 MHz)*δ*: 120.90 (C-1),109.19 (C-2,6), 145.87 (C-3,5), 138.45 (C-4), 170.6 (C-7). Merging experimental and literature data \[[@B37-molecules-23-01720]\], revealed compound **4** to be gallic acid (C~7~H~6~O~5~).

**Compound 5**: ESI-MS *m*/*z*:153.0197 \[M − H\]^−^. ^1^H-NMR (600 MHz, MeOD) δ: 12.20 (1H, br.s, COOH), 8.48 (2H, br.s, OH-3,4), 7.47 (1H, d, *J* = 2.0 Hz, H-2), 6.82 (1H, d, *J* = 8.0 Hz, H-5), 7.45 (1H, dd, *J* = 8.2, 2.1 Hz, H-6);^13^C-NMR (151 MHz, MeOD) δ: 122.44 (C-1), 108.95 (C-2), 149.92 (C-3), 144.60 (C-4), 114.34 (C-5), 116.37 (C-6) and 169.33 (C-7). According to the combined experimental and literature data \[[@B38-molecules-23-01720]\], it was determined that compound **5** was protocatechuic acid (C~7~H~6~O~4~).

**Compound 6**: ESI-MS *m*/*z*: 197.0453 \[M − H\]^−^. ^1^H-NMR (600 MHz, DMSO) δ: 6.97 (2H, s, H-2,6), 4.22 (2H, q, *J* = 7.1 Hz, CH~2~), 1.28 (3H, t, *J* = 7.1 Hz, CH~3~); ^13^C-NMR (151 MHz, DMSO) δ: 120.80 (C-1), 108.96 (C-2,6), 146.03 (C-3,5), 138.82 (C-4), 166.30 (C-7), 60.46 (CH~2~) and 14.72 (CH~3~). Based on the above data and the literature \[[@B39-molecules-23-01720]\], compound **6** was identified as ethyl gallate (C~9~H~10~O~5~).

**Compound 11**: ESI-MS *m*/*z*: 463.0882 \[M − H\]^−^. ^1^H-NMR (600 MHz, DMSO) δ: 7.70 (1H, d, *J* = 2.4 Hz, H-2′), 7.56 (1H, dd, *J* = 2.4, 8.8 Hz, H-6′), 6.84 (1H, d, *J* = 8.6 Hz, H-5′), 6.40 (1H, d, *J* = 2.0 Hz, H-8), 6.20 (1H, d, *J* = 2.0 Hz, H-6), 5.45 (1H, d, *J* = 7.4 Hz, H-1″), 3.22--3.59 (6H, m, H-2″−6″); ^13^C-NMR (151 MHz, DMSO) δ: 156.81 (C-2), 133.80 (C-3), 177.91 (C-4), 161.72 (C-5), 99.15 (C-6), 164.68 (C-7), 93.98 (C-8), 156.64 (C-9), 104.43 (C-10), 122.07 (C-1′), 115.68 (C-2′), 121.65 (C-6′), 116.68 (C-5′), 148.94 (C-4′), 101.36 (C-1″), 74.58 (C-2″), 76.99 (C-3″), 70.42 (C-4″), 78.04 (C-5″) and 61.46 (C-6″). Based on our findings and the literature \[[@B40-molecules-23-01720]\], compound **11** was identified as quercetin-3-*O*-β-[d]{.smallcaps}-glucopyranoside (C~21~H~20~O~12~).

**Compound 12**: ESI-MS *m*/*z* 353.0879 \[M − H\]^−^. ^1^H-NMR (600 MHz, MeOD) δ: 2.24 (2H, m, H-2), 4.19 (1H, br.s, H-3), 3.76 (1H, m, H-4), 5.37 (1H, d, *J* = 4.2 Hz, H-5), 2.10 (2H, m, H-6), 7. 06 (1H, d, *J* = 1.9 Hz, H-2′), 6.79 (1H, d, *J* = 8.2 Hz, H-5′), 6.98 (1H, dd, *J* = 1.9, 8.2 Hz, H-6′), 7.58 (1H, d, *J* = 15.9 Hz, H-7′), 6.28 (1H, d, *J* = 15.9 Hz, H-8′); ^13^C-NMR (151 MHz, DMSO) δ: 74.84 (C-1), 37.47 (C-2), 69.98 (C-3), 70.61 (C-4), 72.15 (C-5), 36.84 (C-6), 175.73 (C-7), 126.43 (C-1′), 113.90 (C-2′), 145.41 (C-3′), 148.17 (C-4′), 115.10 (C-5′), 121.58 (C-6′), 145.69 (C-7′), 113.83 (C-8′) and 167.30 (C-9′). Based on the above data and the literature \[[@B41-molecules-23-01720]\], compound **12** was identified as 5-*O*-caffeoylquinic acid (C~16~H~18~O~9~).

**Compound 14**: ESI-MS *m*/*z* 353.0881 \[M − H\]^−^. ^1^H-NMR (600 MHz, DMSO) δ: 1.79 (2H, m, H-2), 5.07 (1H, m, H-3), 3.78 (1H, m, H-4), 4.75 (1H, br.s, H-5), 1.95 (2H, m, H-6), 7.04 (1H, d, *J* = 1. 9 Hz, H-2′), 6.77 (1H, d, *J* = 8.1 Hz, H-5′), 6.98 (1H, dd, *J* = 1.9, 8.2 Hz, H-6′), 7.42 (1H, d, *J* = 15.9 Hz, H-7′), 6.15 (1H, d, *J* = 15.9 Hz, H-8′); ^13^C-NMR (151 MHz, DMSO) δ: 73.95 (C-1), 37.68 (C-2), 71.34 (C-3), 70.85 (C-4), 68.54 (C-5), 36.72 (C-6), 175.38 (C-7), 126.07 (C-1′), 115.25 (C-2′), 145.40 (C-3′), 148.81 (C-4′), 116.21 (C-5′), 121.81 (C-6′), 146.03 (C-7′), 114.77 (C-8′) and 166.19 (C-9′). Based on the above data and literature findings \[[@B41-molecules-23-01720]\], compound **14** was identified as 3-*O*-caffeoylquinic acid (C~16~H~18~O~9~).

3.3. Antioxidant Activity Analysis of Purified Compounds {#sec3dot3-molecules-23-01720}
--------------------------------------------------------

The antioxidant activity of the purified compounds was tested using DPPH methods ([Table 2](#molecules-23-01720-t002){ref-type="table"}, [Figure 3](#molecules-23-01720-f003){ref-type="fig"}). With the exception of compound **11**, all test compounds showed significant antioxidant activity. The IC~50~ values of compounds **2**, **3**, **11**, **12,** and **14** ranged from 3.00 to 4.05 μg/mL, and all were slightly higher than in the V~C~ control group (2.08 μg/mL). The IC~50~ values of compounds **1**, **4**, **5,** and **6** were 1.88, 1.05, 1.18, and 1.05 μg/mL, respectively, and were significantly lower than those of the V~C~ control group.

4. Conclusions {#sec4-molecules-23-01720}
==============

In this study, UHPLC-Q-TOF-MS/MS and a variety of chromatographic separation techniques were used to systematically analyze and separate the active antioxidant components of LCO. A total of 100 compounds were identified from the 70% ethanol extract of LCO, and these were mainly gallic acid tannins and flavonoids. Of these, 18 pure compounds were isolated, with compounds **2**, **5**, **6**, **12**, **14,** and **16**--**18** identified for the first time in LCO and the genus Loropetalum. DPPH results showed that compounds **1**, **4**, **5,** and **6** had significant antioxidant activity.
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**Sample Availability:** Samples of the compounds 1,2,3,4,6-penta-*O*-galloyl-β-[d]{.smallcaps}-glucose, 3,4,5-trimethoxyphenyl-(6′-*O*-galloyl)-*O*-β-[d]{.smallcaps}-glucopyranoside, 6′-*O*-galloylsalidroside, gallic acid, protocatechuic acid, ethyl gallate, tiliroside, 3-*O*-coumaroylquinicacid, kaempferol-3-*O*-β-[d]{.smallcaps}-galactopyranosyl-(1→6)-β-[d]{.smallcaps}-glucopyranoside, kaempferol-3-*O*-β-[d]{.smallcaps}-galactopyranoside, quercetin-3-*O*-β-[d]{.smallcaps}-glucopyranoside, 5-*O*-caffeoylquinic acid, 3-*O*-coumaroylquinic acid methyl ester, 3-*O*-caffeoylquinic acid, 5-*O*-coumaroylquinic acid, 3,5-*O*-diocaffeoylquinic acid, 4,5-*O*-diocaffeoylquinic acid, 3,4-*O*-diocaffeoylquinic acid are available from the authors.

The following are available online. Figure S1: The structure of compound **1**\~**18**.
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![BPI chromatograms of *Loropetalum chinense*(*R. Brown*) Oliv. (LCO) in negative ion mode (**A**) and in positive ion mode (**B**).](molecules-23-01720-g001){#molecules-23-01720-f001}

![The MS/MS spectrum information of different compounds in LCO. (**A1**) Peak 5; (**A2**) Peak 4; (**B1**) Peak 66; (**B2**) Peak 89.](molecules-23-01720-g002){#molecules-23-01720-f002}

![The IC~50~ values of purified compounds in LCO on antioxidant activity.](molecules-23-01720-g003){#molecules-23-01720-f003}

molecules-23-01720-t001_Table 1

###### 

Identification of the chemical constituents in *Loropetalum chinense*(*R. Brown*) Oliv. (LCO) by HPLC--ESI-Q-TOF-MS/MS.

  No.   tR/Min   Formula           Error/ppm   Adduct         Found at Mass/Da   MS^2^ Ions                                                                       Indentification
  ----- -------- ----------------- ----------- -------------- ------------------ -------------------------------------------------------------------------------- -----------------------------------------------------------------------------------
  1     1.21     C~14~H~16~O~10~   −0.1        \[M + H\]^+^   345.0815           171.0275, 153.0179, 125.0235                                                     Theogallin
  2     1.32     C~13~H~16~O~10~   0.2         \[M − H\]^−^   331.0671           331.0671, 169.0144, 125.0243                                                     Monogalloyl glucose
  3     1.32     C~7~H~12~O~6~     −0.8        \[M + H\]^+^   193.0706           175.0608, 147.0656, 129.0551                                                     Quinic acid
  4     1.66     C~14~H~16~O~10~   0.5         \[M + H\]^+^   345.0818           327.0726, 171.0289, 153.0185, 125.0232                                           Theogallin
  5     1.75     C~7~H~6~O~5~      −2.4        \[M + H\]^+^   171.0284           153.0180, 135.0074, 125.0234, 109.0286, 107.0128, 97.0283                        Gallic acid
  6     1.97     C~13~H~16~O~10~   0.7         \[M − H\]^−^   331.0673           331.0673, 169.0130, 125.0241                                                     Monogalloyl glucose
  7     2.35     C~13~H~16~O~10~   −0.1        \[M − H\]^−^   331.0672           331.0672, 169.0144, 125.0242                                                     Monogalloyl glucose
  8     2.86     C~13~H~16~O~10~   −0.1        \[M − H\]^−^   331.0671           331.0671, 169.0142, 125.0249                                                     Monogalloyl glucose
  9     3.63     C~7~H~6~O~4~      −1.7        \[M + H\]^+^   155.0336           137.0230, 109.0288, 107.0112, 93.0343, 81.0343                                   Protocatechuic acid
  10    3.63     C~27~H~22~O~18~   2.6         \[M − H\]^−^   633.0750           633.0750, 481.0649, 300.0992, 169.0153, 125.0232                                 Corilagin
  11    3.64     C~13~H~16~O~10~   0.9         \[M − H\]^−^   331.0674           331.0685, 169.0148, 151.0031, 125.0257                                           Monogalloyl glucose
  12    4.06     C~20~H~20~O~14~   1           \[M − H\]^−^   483.0785           483.0786, 331.0673, 313.0568, 169.0145, 151.0038, 125.0249                       Digalloylglucose
  13    4.07     C~19~H~26~O~15~   0.3         \[M − H\]^−^   493.1201           493.1201, 331.0648, 169.0142, 125.0248                                           Gallic acid diglucoside
  14    4.26     C~13~H~16~O~10~   −0.1        \[M − H\]^−^   331.0670           331.0670, 169.0141, 125.0250                                                     Monogalloyl glucose
  15    4.49     C~19~H~26~O~15~   1           \[M − H\]^−^   493.1204           493.1204, 331.0688, 313.0565, 169.0149, 125.0243                                 Gallic acid diglucoside
  16    4.52     C~27~H~22~O~18~   3.4         \[M − H\]^−^   633.0752           633.0752, 481.0608, 463.0505, 300.0992, 169.0138, 125.0255                       Corilagin
  17    4.77     C~8~H~8~O~5~      −3.8        \[M + H\]^+^   185.0437           125.0305, 107.0121, 81.0340                                                      Methyl gallate
  18    4.79     C~20~H~20~O~14~   0.8         \[M − H\]^−^   483.0784           483.0784, 331.0676, 313.0566, 169.0150, 151.0041, 125.0254                       Digalloylglucose
  19    5.31     C~27~H~22~O~18~   3.5         \[M − H\]^−^   633.0755           633.0755, 463.0597, 300.0980, 169.0152                                           Corilagin
  20    5.33     C~20~H~20~O~14~   1.2         \[M − H\]^−^   483.0786           483.0786, 331.0677, 313.0571, 169.0143, 151.0035, 125.0249                       Digalloylglucose
  21    5.81     C~27~H~22~O~18~   2.8         \[M − H\]^−^   633.0751           633.0751, 481.0757, 463.0505, 300.0989, 169.0143, 125.0246                       Corilagin
  22    5.89     C~16~H~18~O~9~    0.7         \[M − H\]^−^   353.0889           191.0565, 179.0347, 173.0445, 161.0249, 135.0447                                 Caffeoylquinic acid
  23    5.99     C~27~H~24~O~18~   −3          \[M − H\]^−^   635.0955           635.0955, 483.0799, 465.0670, 331.0694, 313.0574, 169.0143, 125.0253             Trigalloylglucopyranose
  24    6.02     C~14~H~10~O~9~    −0.8        \[M + H\]^+^   323.0395           153.0179, 125.0233, 79.0185                                                      Digallic acid
  25    6.84     C~8~H~8~O~5~      −1.1        \[M + H\]^+^   185.0442           153.0183, 135.0078, 125.0236, 107.0103, 97.0282                                  Methyl gallate
  26    6.88     C~27~H~24~O~18~   2.9         \[M − H\]^−^   635.0908           635.0908, 483.0788, 465.0700, 331.0683, 313.0579, 169.0149, 125.0252             Trigalloylglucopyranose
  27    6.92     C~27~H~22~O~18~   3.5         \[M − H\]^−^   633.0749           633.0749, 300.0981, 169.0150, 125.0239                                           Corilagin
  28    7.09     C~16~H~18~O~9~    0.3         \[M − H\]^−^   353.0878           191.0554, 179.0344, 173.0446, 161.0242, 135.0447                                 Chlorogenic acid
  29    7.43     C~27~H~30~O~16~   −1.1        \[M + H\]^+^   611.1784           611.1784, 449.1066, 287.0559                                                     Panasenoside
  30    7.50     C~27~H~24~O~18~   3.3         \[M − H\]^−^   635.0910           635.0913, 483.0789, 465.0687, 331.0698, 313.0567, 169.0145, 125.0241             Trigalloylglucopyranose
  31    7.51     C~27~H~22~O~18~   3.2         \[M − H\]^−^   633.0753           633.0753, 481.0729, 300.0991, 169.0145, 125.0255                                 Corilagin
  32    7.63     C~9~H~10~O~5~     −2          \[M + H\]^+^   199.0597           181.0502, 153.0190, 140.0470, 125.0232, 107.0121, 97.0288                        Ethyl gallate
  33    7.87     C~15~H~10~O~5~    0.2         \[M + H\]^+^   271.0599           271.0599, 215.0699, 177.0559, 169.0641, 153.0569, 149.0246, 119.0509             Apigenin
  34    7.87     C~22~H~18~O~11~   −1.4        \[M + H\]^+^   459.0915           459.0915, 307.0381, 289.0714, 163.0391, 153.0178, 151.0391, 139.0389             Epigallocatechin Gallate
  35    7.97     C~27~H~30~O~16~   −2.2        \[M + H\]^+^   611.1593           449.1059, 303.0484, 287.0534, 267.0019, 145.0489, 85.0278                        Rutin
  36    8.14     C~16~H~18~O~8~    0.3         \[M + H\]^+^   339.1073           165.0545, 147.0441, 119.0489, 91.0548, 65.0396                                   Coumaroylquinic acid
  37    8.18     C~16~H~18~O~9~    0.4         \[M − H\]^−^   353.0878           191.0558, 179.0328, 173.0328, 161.0243, 135.0456                                 Caffeoylquinic acid
  38    8.18     C~27~H~24~O~18~   3.3         \[M − H\]^−^   635.0911           635.0911, 483.0789, 465.0690, 313.0567, 169.0143, 125.0247                       Trigalloylglucopyranose
  39    8.97     C~21~H~24~O~11~   −1.1        \[M + H\]^+^   453.1386           453.1386, 406.9998, 315.0727, 297.0602, 255.0507, 171.0283, 153.0178, 127.0393   Galloylsalidroside
  40    9.08     C~17~H~20~O~9~    −0.8        \[M + H\]^+^   369.1177           195.0656, 177.0547, 149.0588, 145.0283, 134.0349, 117.0344, 89.0394              Feruloylquinic acid
  41    9.10     C~27~H~24~O~18~   1.7         \[M − H\]^−^   635.0901           635.0901, 483.0800, 465.0679, 331.0694, 313.0566, 169.0140, 125.0253             Trigalloylglucopyranose
  42    9.20     C~34~H~28~O~22~   2.8         \[M − H\]^−^   787.1021           787.1021, 635.0919, 617.0798, 483.0752, 465.0682, 313.0566, 169.0142, 125.0249   Tetrakisgalloylglucopyranose
  43    9.35     C~16~H~18~O~8~    0.3         \[M + H\]^+^   339.1073           147.0440, 119.0492, 91.0548, 65.0395                                             Coumaroylquinic acid
  44    9.85     C~41~H~32~O~26~   −6.3        \[M − H\]^−^   939.1050           939.1050, 787.0948, 769.0879, 635.0942, 617.0738, 313.0576, 169.0147             Pentagalloylglucopyranose
  45    10.00    C~34~H~28~O~22~   3.4         \[M − H\]^−^   787.1026           787.1026, 635.0921, 617.0811, 483.0785, 465.0679, 313.0555, 169.0141, 125.0245   Tetrakisgalloylglucopyranose
  46    10.21    C~22~H~26~O~13~   −0.9        \[M + H\]^+^   499.1442           315.0719, 297.0616, 275.0925, 255.0505, 185.0814, 171.0294, 153.0189, 127.0389   1-*O*-3′,4′,5′-trimethoxyphenyl-(6-*O*-galloyl)-β-[d]{.smallcaps}-glucopyranoside
  47    10.22    C~28~H~24~O~16~   −0.9        \[M + H\]^+^   617.1131           617.1131, 447.0910, 303.0503, 297.0610, 153.0184                                 Galloylhyperin
  48    10.29    C~34~H~28~O~22~   3.5         \[M − H\]^−^   787.1027           787.1027, 635.0934, 617.0827, 483.0827, 465.0697, 313.0571, 169.0152, 125.0255   Tetrakisgalloylglucopyranose
  49    10.51    C~28~H~24~O~16~   −1.9        \[M + H\]^+^   617.1129           617.1147, 447.0920, 237.0385, 153.0189                                           Galloylhyperin
  50    10.51    C~22~H~18~O~10~   −0.9        \[M + H\]^+^   443.0969           273.0757, 165.0549, 153.0179, 151.0386, 147.0431, 139.0385, 123.0438             Catechin gallate
  51    10.52    C~15~H~12~O~5~    −0.3        \[M + H\]^+^   273.0757           273.0760, 163.0402, 153.0192, 147.0424, 135.0436, 123.0440, 105.0326             Naringenin
  52    10.63    C~21~H~18~O~13~   −1.2        \[M + H\]^+^   479.0814           317.0294, 285.0024, 257.0061                                                     Shikimic acid-*O*-digallate
  53    10.63    C~34~H~28~O~22~   3.6         \[M − H\]^−^   787.1028           787.1028, 635.0925, 617.0823, 483.0829, 465.0656, 313.0557, 169.0143, 125.0246   Tetrakisgalloylglucopyranose
  54    10.76    C~14~H~6~O~8~     0.3         \[M + H\]^+^   303.0140           303.0140, 285.0035, 275.0189, 257.0082, 229.0130, 201.0179, 173.0232, 145.0284   Ellagic acid
  55    10.78    C~15~H~10~O~8~    0.1         \[M + H\]^+^   319.0449           319.0450, 301.0346, 290.0422, 273.0393, 245.0444, 217.0503, 165.0176, 153.0182   Myricetin
  56    10.94    C~21~H~20~O~12~   −0.6        \[M + H\]^+^   465.1028           319.0453, 303.0507, 285.0388, 257.0455, 229.0497, 145.0498, 127.0387, 97.0290    Myricitrin
  57    10.96    C~15~H~10~O~7~    −0.7        \[M + H\]^+^   303.0497           303.0497, 285.0037, 275.0176, 257.0436, 229.0493, 153.0181 137.0229              Isomer of Quercetin
  58    11.21    C~21~H~20~O~12~   −0.7        \[M + H\]^+^   465.1025           303.0508, 257.0446, 229.0492, 165.0176, 145.0491, 127.0389, 97.0289, 85.0289     Hyperoside
  59    11.22    C~15~H~10~O~7~    0.2         \[M + H\]^+^   303.0503           303.0503, 285.0389, 257.0457, 229.0498, 153.0181 137.0232                        Isomer of Quercetin
  60    11.40    C~21~H~20~O~11~   −1.1        \[M + H\]^+^   449.1073           287.0545, 153.0178                                                               Luteoloside
  61    11.66    C~41~H~32~O~26~   2.4         \[M − H\]^−^   939.1131           939.1131, 787.0943, 769.0877, 635.0796, 617.0789, 313.0644, 169.0141, 125.0259   Pentagalloylglucopyranose
  62    11.73    C~15~H~10~O~7~    −0.7        \[M + H\]^+^   303.0497           303.0497, 285.0367, 257.0453, 229.0478, 153.0186, 137.0591                       Isomer of Quercetin
  63    11.96    C~20~H~18~O~11~   −1          \[M + H\]^+^   435.092            303.0500, 285.0415, 257.0448, 229.0493, 153.0179, 137.0217                       Isomer of guaijaverin
  64    12.06    C~15~H~10~O~6~    0.2         \[M + H\]^+^   287.0542           287.0542, 258.0511, 241.0482, 213.0550, 165.0167, 153.0178, 137.0218, 121.0282   Isomer of Kaempferol
  65    12.07    C~21~H~20~O~11~   −0.3        \[M + H\]^+^   449.1075           287.0560, 165.0177, 153.0182                                                     Isomer of luteoloside
  66    12.16    C~28~H~24~O~15~   6.6         \[M − H\]^−^   599.1088           599.1088, 447.0969, 313.0582, 285.0414, 169.0147, 151.0036, 125.0245             Astragalin-*O*-gallate
  67    12.22    C~41~H~32~O~26~   2.6         \[M − H\]^−^   939.1133           939.1133, 787.1020, 769.0979, 635.0901, 617.0780, 313.0514, 169.0142, 125.0262   Pentagalloylglucopyranose
  68    12.54    C~25~H~24~O~12~   0.6         \[M − H\]^−^   515.1195           515.1195, 353.0883, 191.0556, 179.0343, 135.0449                                 Dicaffeoylquinic acids
  69    12.55    C~15~H~10~O~6~    0.3         \[M + H\]^+^   287.0552           287.0552, 258.0525, 241.0483, 213.0533, 165.0188, 157.0469, 153.0183, 121.0285   Isomer of Kaempferol
  70    12.63    C~21~H~20~O~11~   −0.7        \[M + H\]^+^   449.1075           303.0511, 287.0562, 165.0178, 145.0496, 129.0548, 127.0387                       Quercitrin
  71    12.67    C~15~H~10~O~7~    0.6         \[M + H\]^+^   303.0505           303.0505, 285.0395, 257.0445, 229.0494, 153.0182, 137.0231                       Isomer of Quercetin
  72    12.97    C~16~H~12~O~7~    1.8         \[M + H\]^+^   317.0653           317.0653, 302.0437, 285.0415, 274.0482, 246.0531, 229.0483, 153.0182             Isomer of isorhamnetin
  73    12.99    C~28~H~24~O~15~   7.6         \[M − H\]^−^   599.1064           599.1064, 447.0947, 313.0577, 285.0408, 169.0136, 151.0035, 125.0238             Astragalin-*O*-gallate
  74    13.02    C~15~H~10~O~6~    0.4         \[M + H\]^+^   287.0552           287.0552, 258.0533, 231.0647, 213.0545, 165.0171, 153.0175, 137.0236, 121.0286   Isomer of Kaempferol
  75    13.04    C~35~H~28~O~19~   −1.8        \[M + H\]^+^   753.1284           467.0822.449.0706, 315.0705, 287.0552, 153.0181, 125.0236                        Astragalin-*O*-digallate
  76    13.30    C~15~H~10~O~6~    0.4         \[M + H\]^+^   287.0561           287.0561, 258.0566, 213.0567, 165.0193, 153.0175, 147.0429, 137.0240             Isomer of Kaempferol
  77    13.68    C~23~H~24~O~12~   −1.6        \[M + H\]^+^   493.1332           493.1332, 331.0819, 315.0505, 270.0515                                           Tricin-*O*-glucopyranoside
  78    13.72    C~35~H~28~O~19~   −2          \[M + H\]^+^   753.1283           753.1261, 601.1206, 467.0812, 449.0707, 287.0547, 237.0393, 153.0185             Astragalin-*O*-digallate
  79    14.27    C~15~H~10~O~6~    0.5         \[M + H\]^+^   287.0546           287.0546, 258.0527, 241.0491, 213.0551, 165.0180, 153.0181, 137.0233, 121.0285   Isomer of Kaempferol
  80    14.27    C~21~H~20~O~10~   −1          \[M + H\]^+^   433.1125           287.0553, 165.0183, 129.0542, 85.0285, 71.0498                                   Kaempferol-*O*-rhamnoside
  81    14.32    C~23~H~24~O~12~   −1.5        \[M + H\]^+^   493.3333           331.0814, 315.0496, 270.0519                                                     Isomer of tricin-*O*-glucopyranoside
  82    14.32    C~35~H~28~O~19~   −2.5        \[M + H\]^+^   753.1279           753.1366, 601.1066, 467.0804, 449.0691, 287.0543, 237.0403, 153.0183             Isomer of astragalin-di-*O*-gallate
  83    14.64    C~16~H~12~O~7~    1.3         \[M + H\]^+^   317.0649           317.0649, 302.0442, 285.0392, 246.0505, 175.9679, 153.0188, 139.0399             Isomer of isorhamnetin
  84    14.69    C~30~H~26~O~13~   9.4         \[M − H\]^−^   593.1360           593.1360, 447.0949, 307.0825, 285.0413, 163.0403, 151.0030, 145.0290, 119.0508   Isomer of Tribuloside
  85    16.27    C~15~H~10~O~7~    0.4         \[M + H\]^+^   303.0503           303.0503, 285.0399, 257.0445, 229.0491, 201.0552, 153.0182, 137.0230             Quercetin
  86    16.36    C~15~H~10~O~6~    −0.6        \[M + H\]^+^   287.0553           287.0553, 161.0234, 153.0183, 135.0434                                           Isomer of Kaempferol
  87    16.72    C~16~H~12~O~7~    −0.7        \[M + H\]^+^   317.0569           317.0569, 302.0420, 274.0469, 228.0420, 153.0170, 147.0435                       Isorhamnetin
  88    16.88    C~15~H~10~O~6~    0.8         \[M + H\]^+^   287.0547           287.0547, 258.0507, 241.0461, 213.0539, 165.0182, 153.0179, 121.0281             Isomer of Kaempferol
  89    16.89    C~30~H~26~O~13~   6.8         \[M − H\]^−^   593.1341           593.1341, 447.0955, 307.0835, 285.0399, 163.0398, 151.0038, 145.0296, 119.0506   Tribuloside
  90    16.89    C~22~H~22~O~10~   −1.3        \[M + H\]^+^   447.128            301.0705, 286.0479, 258.0536, 153.0179                                           Methylluteolin-*O*-rhamnopyranosid
  91    17.34    C~17~H~14~O~7~    −0.2        \[M + H\]^+^   331.0812           331.0820, 315.0498, 286.0462, 270.0522, 258.0520                                 Quercetin-dimethyl ether
  92    17.39    C~15~H~10~O~6~    0.8         \[M + H\]^+^   287.055            287.0550, 258.0539, 241.0463, 213.0522, 165.0175, 153.0190, 121.0279             Isomer of Kaempferol
  93    17.39    C~30~H~26~O~13~   5.8         \[M − H\]^−^   593.1354           593.1354, 447.0938, 307.0828, 285.0403, 163.0396, 151.0031, 145.0290, 119.0505   Isomer of Tribuloside
  94    17.48    C~22~H~22~O~10~   −0.9        \[M + H\]^+^   447.1281           301.0710, 286.0490, 258.0527                                                     Methylluteolin-*O*-rhamnopyranosid
  95    18.11    C~15~H~12~O~5~    −0.8        \[M + H\]^+^   273.0755           273.0736, 164.8737, 153.0183, 147.0432, 121.0273, 91.0557                        Isomer of naringenin
  96    19.05    C~15~H~10~O~6~    0.9         \[M + H\]^+^   287.0557           287.0557, 258.0527, 241.0494, 231.0652, 213.0550, 165.0185, 153.0184, 121.0286   Kaempferol
  97    19.52    C~17~H~14~O~7~    0.7         \[M + H\]^+^   331.0183           331.0819, 315.0505, 286.0477, 270.0529, 258.0529, 242.0583                       Quercetin-dimethyl ether
  98    19.76    C~16~H~12~O~7~    −0.9        \[M + H\]^+^   317.0657           317.0657, 302.0424, 274.0464, 153.0185                                           Isomer of isorhamnetin
  99    19.97    C~20~H~18~O~11~   −1.1        \[M + H\]^+^   435.0924           435.0924, 237.0398, 153.0175, 127.0406                                           Guaijaverin
  100   20.71    C~17~H~14~O~7~    −0.3        \[M + H\]^+^   331.0809           331.0807, 315.0495, 286.0538, 270.0528, 242.0549, 168.0608                       Quercetin-dimethyl ether
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The antioxidant activity of purified compounds.

  --------------------- ----------------------- -------------- -------------- -------------- -------------- -------
  Vc                    Concentration (µg/mL)   0.73           1.16           1.45           2.18           2.90
  Inhibition rate (%)   18.71 ± 0.17            24.26 ± 0.36   34.79 ± 0.47   46.19 ± 0.28   69.15 ± 0.45   
  1                     Concentration (µg/mL)   0.88           1.75           2.63           2.98           3.50
  Inhibition rate (%)   20.03 ± 0.15            37.09 ± 0.22   63.64 ± 0.26   69.15 ± 0.40   85.93 ± 0.11   
  2                     Concentration (µg/mL)   2.31           2.78           3.24           3.70           4.63
  Inhibition rate (%)   29.08 ± 0.20            45.43 ± 0.31   52.63 ± 0.11   62.32 ± 0.35   87.81 ± 0.13   
  3                     Concentration (µg/mL)   2.33           3.72           4.65           5.58           6.98
  Inhibition rate (%)   25.99 ± 0.14            46.53 ± 0.15   59.59 ± 0.31   71.43 ± 0.24   87.76 ± 0.16   
  4                     Concentration (µg/mL)   0.52           0.87           1.21           1.56           2.08
  Inhibition rate (%)   22.33 ± 0.25            38.75 ± 0.27   52.23 ± 0.36   67.66 ± 0.40   82.14 ± 0.43   
  5                     Concentration (µg/mL)   0.76           1.01           1.68           1.89           2.10
  Inhibition rate (%)   26.66 ± 0.37            38.02 ± 0.33   67.52 ± 0.28   78.21 ± 0.19   81.00 ± 0.40   
  6                     Concentration (µg/mL)   0.61           1.01           1.41           1.82           2.02
  Inhibition rate (%)   26.25 ± 0.27            42.90 ± 0.32   59.54 ± 0.33   76.50 ± 0.27   86.47 ± 0.33   
  10                    Concentration (µg/mL)   10.63          21.25          25.5           31.88          42.50
  Inhibition rate (%)   27.55 ± 0.29            50.94 ± 0.19   61.29 ± 0.26   78.36 ± 0.41   87.37 ± 0.37   
  11                    Concentration (µg/mL)   1.38           3.22           3.68           4.14           9.20
  Inhibition rate (%)   25.40 ± 0.27            47.85 ± 0.26   63.16 ± 0.29   75.07 ± 0.33   88.54 ± 0.33   
  12                    Concentration (µg/mL)   0.99           2.46           7.39           9.85           12.31
  Inhibition rate (%)   22.33 ± 0.39            46.55 ± 0.40   68.06 ± 0.50   72.53 ± 0.31   74.79 ± 0.25   
  14                    Concentration (µg/mL)   2.23           3.56           4.45           6.68           8.01
  Inhibition rate (%)   27.06 ± 0.19            39.51 ± 0.51   46.28 ± 0.37   66.85 ± 0.24   88.77 ± 0.31   
  --------------------- ----------------------- -------------- -------------- -------------- -------------- -------

[^1]: These authors contributed equally to this work.
